How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease
Intern Med
.
2024 Jan 2.
doi: 10.2169/internalmedicine.2725-23.
Online ahead of print.
Authors
Hayato Fujioka
1
,
Naoya Kataoka
1
,
Teruhiko Imamura
1
Affiliation
1
The Second Department of Internal Medicine, University of Toyama, Japan.
PMID:
38171852
DOI:
10.2169/internalmedicine.2725-23
No abstract available
Keywords:
SGLT2 inhibitor; cardiovascular disease; heart failure; uric acid.